Sub-Saharan Africa accounted for approximately 93% of all malaria cases and 94% of deaths in 2018
Aetiology
- Plasmodium parasite from female anopheles mosquito
- P. falciparum most severe - can cross the blood-brain barrier
Clinical presentation
- P. falciparum can rapidly progress to severe cerebral malaria, seizures and coma
Investigations
- Blood film for microscopy or rapid diagnostic test
Management
Treatment
- Aremisinin-based combination therapy (ACT) for 3 days
- Severe malaria - IM or IV artesunate until can tolerate oral treatment
Prevention
- In high transmission areas give preventative treatment to all infants alongside routine vaccines
- Long-lasting insecticidal nets (LLINs)
- Pilot projects for malaria vaccine